Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Investor Presentation (December 2024)
70 slides from Apollo Hospitals Enterprise's investor presentation, December 2024
Slide 1: Apollo Hospitals Enterprise Limited Investor Presentation December 2024
Apollo Hospitals Enterprise Limited Investor Presentation December 2024
Slide 2: Disclaimer
Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor an
Slide 3: Content
Content India’s Largest Integrated Healthcare System Clinical Pioneers Attractive Industry Opportunity Strong Financial & Operational Track Record Prioritizing ESG Annexure © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 3
Slide 4: India's Largest Integrated Healthcare System
India’s Largest Integrated Healthcare System © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 4
Slide 5: India's Largest Integrated Healthcare System
India’s Largest Integrated Healthcare System Apollo Specialty Services Apollo • Culture of innovation Hospitals CLINICAL • Clinical expertise OUTCOMES Apollo APOLLO CLINICS Pan–India • Learning Organisation Health Checks (Retail Healthcare) Hospitals One Patient, Empowered and engaged patients; fost
Slide 6: Largest Hospital Chain in India
Largest Hospital Largest Offline India’s Leading Retail 3rd Largest Private Chain in India Pharmacy in India Healthcare Network Health Insurer in India 73 hospitals 6300+ stores in 1200+ cities and 263 primary clinics, 200 dental Fastest insurer to reach 10,169 beds towns clinics, 74 sugar clinics,
Slide 7: Largest Pan India Hospital Chain
Largest Pan India Hospital Chain Capacity Operational Hospitals Census Beds1 Census Beds Overall Total 73 10,169 9,429 Delhi: 5 Amritsar: 1 Noida: 1 Owned Hospitals 45 8,736 7,996 Bilaspur: 1 Kanpur: 1 Lucknow: 1 Indirapuram: 1 Managed Hospitals 6 790 790 Jaipur: 1 Day Surgery & 22 643 643 Cradle (A
Slide 8: AHLL: Transforming Retail Health through access and convenience
AHLL: Transforming Retail Health through access and convenience Apollo Health & Lifestyle Ltd Out-of-Hospital care • Outpatient Clinics • Diagnostics • Day Surgery centers • Single Specialty Facilities :- Dialysis, Sugar and Dental Organizing the unorganized • Pathology – Organized chains represent
Slide 9: AHL | India's Largest Omni-channel Healthcare Platform
AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd Apollo 24|7 Apollo Telehealth* Offline Pharmacy Distribution Unmatched Size • Provides comprehensive remote • 38 Mn.+ Registered Users – 785,500 Daily healthcare services. • India’s largest Organized Pharmacy Platform with Act
Slide 10: Clinical Pioneers
Clinical Pioneers © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 10
Slide 11: Clinical pioneers bringing in tectonic shifts in the healthcare industry
Clinical pioneers bringing in tectonic shifts in the healthcare industry Bringing in Latest Technologies First 25 Robotic Advanced G4 Proton therapy 640 surgical systems Diagnostics Cyber-knife for cancer slice CT Largest minimally First MRI, CT, Pet CT in Asia Pacific’s most First in South East Asi
Slide 12: Patient First Mindset
Patient First Mindset Clinical Excellence Service Excellence Execution Excellence Medically Known for Patient Care Through The Apollo Family Value for Money Clinical Excellence Service Excellence COEs Patient Care Plan Clinician Engagement Case Mix Outcomes Ward as a unit Best places to work Communi
Slide 13: Quality Framework
Quality Framework Apollo Hospitals Group aims at establishing the highest standards of clinical care and patient safety for all its hospitals irrespective of their location or size. Zero Harm Initiative Apollo Clinical Excellence 3.0 Anti-Microbial Stewardship Outcomes Review Program Daily Tiered-Hu
Slide 14: Excellence Driven by Academics, Skilling and Research
Excellence Driven by Academics, Skilling and Research Academics Skilling Research Global Workforce Development Apollo Med Skills Campus Education AIMSR, Hyderabad 11 Nursing schools Learn, Earn, Excel, Settle or Return The official in India journal of Apollo AIMSR, Chittoor Healthcare sourcing – tra
Slide 15: Early mover and adopter of advances in Clinical AI
Early mover and adopter of advances in Clinical AI 5 Key Themes in AI In Collaboration with: Clinical Intelligence Engine 1 Million API Discharge Risk Scores Calls in FY24 prediction in 24/48 Throughput and Disease hours 2 Million+ Optimization Progression API Calls Models Gen AI for Discharge since
Slide 16: Resulting in Higher Clinical Volumes
Resulting in Higher Clinical Volumes Pioneers in cutting edge treatment FY24 Centers of Excellence First combined First kidney & Liver liver transplant ~78,000 Cardiac transplant Procedures1 ~272,000 Radiotherapy Fractions First simultaneous First bilateral Minimally Kidney-Pancreas Invasive Knee 37
Slide 17: Attractive Industry Opportunity
Attractive Industry Opportunity © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 17
Slide 18: Hugely under-penetrated market with attractive dynamics
Hugely under-penetrated market with attractive dynamics Indian healthcare delivery market poised for robust growth in the medium term Public healthcare expenditure is low, with private sector Healthcare delivery landscape includes… Growing Indian Healthcare Delivery industry accounting for a lion’s
Slide 19: Unlocking growth opportunities
Unlocking growth opportunities….. The impact of Infrastructure lag and shifting market demands ………Infrastructure Lag ………increasing NCDs Hospital beds (per 10,000 population) Physicians (per 10,000 population) Nurses (per 10,000 population) Others Other NCDs World Avg - ~29 World Avg - ~16 7 World Av
Slide 20: Rapid adaption of digital and telecom infrastructure
…… Rapid adaption of digital and telecom infrastructure By 2025, Digital Will Transform India’s Economy, Sector By Sector Emerging technologies in Healthcare delivery Internet Subscriber’s growth…. CAGR : 5-6% Growth potential 170X Financial Services $170bn Telemedicine E-pharmacy 1,100 70X 825 825
Slide 21: "Heal in India" Global hub for medical and wellness tourism
“Heal in India” Global hub for medical and wellness tourism HEAL IN INDIA The medical tourism Growth in medical tourism expected Initiative, aims to promote market valued at primarily due to (i) Technologically Treatments mostly sought after Medical Value Travel USD 6 billion in advanced hospitals (
Slide 22: Strong Financial & Operational Track Record
Strong Financial & Operational Track Record © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 22
Slide 23: Strong Growth in Revenues across Business
Strong Growth in Revenues across Business FY24 FY13-FY24 FY13-FY24 FY13-FY24 $2.29 billion 16% 14% 20% Consolidated Revenue1 CAGR (HCS incl AHLL) CAGR (Pharmacy)2 CAGR (Consolidated Rev) 98,670 Healthcare services SAP Others 86,768 83,255 79,891 78,269 73,045 67,045 67,167 57,297 58,002 51,426 48,20
Slide 24: Aided by Strong Operating Metrics
…… Aided by Strong Operating Metrics In-patient Admissions (‘000) Bed Occupancy Rate(1) % Operating Beds 540 569 5,153 5,549 5,811 6,321 6,724 6,940 7,111 7,246 7,491 7,409 7,875 7,860 7,945 7,911 7,996 478 460 457 399 428 451 423 374 71% 72% 71% 69% 354 352 68% 66% 68% 67% 65% 65% 313 332 63% 64% 6
Slide 25: and Healthy Return on Capital Employed
……and Healthy Return on Capital Employed ROCE – Healthcare Services Offline Pharmacy Distribution excl 24|7 Operating cost 46% Healthcare services excluding CWIP HealthCo 39% 33% 31% 31% SAP 25% 26% 20% 21% 19% 17% 14% 14% 16% 15% 13% 14% 14% 15% 15% 11% 10% 11% 10% 9% 6% 6% 7% 3% FY 09 FY 10 FY 11
Slide 26: Financial Performance Snapshot YTD Dec24
Financial Performance Snapshot YTD Dec24 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) Margin YoY(%) PAT YoY(%) Healthcare Services 83,255 14% 20,144 24.2% 14% 10,409 12.5% 20% Offline PD ^ 59,299 15% 4,509 7.6% 16% Apollo HealthCo Online PD^ & (3,196) 7,868 19% Vs (4,828) in YT
Slide 27: Financial Performance Snapshot Q3FY25
Financial Performance Snapshot Q3FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) Margin YoY(%) PAT YoY(%) 14% Healthcare Services 24.1% 21% 27,850 13% 6,706 3,483 12.5% Offline PD ^ 20,786 14% 1,593 7.7% 19% Apollo HealthCo Online PD^ & 2,737 22% (1,027) Vs (1,322) in Q3F24 2
Slide 28: Consolidated Financials
Consolidated Financials Consolidated Financials © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 28
Slide 29: Consolidated Financials YTD Dec24
Consolidated Financials YTD Dec24 (` mio) Digital Health Overall Consolidated Revenue grew by 15% to ` 162,018 mio. Healthcare Diagnostics & ` Mio & Pharmacy Consol Services Retail Health EBITDA grew by 29% to ` 22,521 mio. Distribution Total Revenues 83,255 11,596 67,167 162,018 EBITDA (Pre 24|7 Co
Slide 30: Consolidated Financials Q3FY25
Consolidated Financials Q3FY25 (` mio) Digital Health Healthcare Diagnostics & Overall Consolidated Revenue grew by 14% to ` 55,269 mio. ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 27,850 3,895 23,524 55,269 EBITDA grew by 24% to ` 7,615 mio. EBITDA (Pre 24|7 Cost) 6,7
Slide 31: Healthcare Services Hospitals
Healthcare Services Hospitals © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 31
Slide 32: Healthcare Services Financials
Healthcare Services Financials (` mio) YTD YTD ` Mio Q3FY25 Q3FY24 YoY YoY Dec24 Dec23 No of Hospitals 45 45 45 45 Healthcare Services Revenue grew by 13% in Q3FY25 Operating beds 7,996 7,911 1% 7,996 7,911 1% (Inpatient Volume grew by 5% ; Price & case mix of 8%) Occupancy 68% 66% 69% 65% IP Discha
Slide 33: Inpatients Revenue Mix YTD Dec24
Inpatients Revenue Mix YTD Dec24 Paed IPS Transplts Uro PSU & Govt 3% Cardio 3% 6% Nephro 3% 18% 10% 4% Self Pay Obs&Gynac 4% Gen Surg 4% 40% 7% Inpatient Inpatient Others Specialty Mix Payor Mix 17% Onco* 10% Internal Med 10% 44% 6% Gastro 10% Neuro Insurance Ortho * Oncology includes Radiotherapy
Slide 34: Healthcare Services: Operational Snapshot
Healthcare Services : Operational Snapshot Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi YTD Dec 24 Metros Non Metros Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating Indore, Guwahati, Madurai, Trichy, 4,549 3,447 Nellore,Vizag, Kakinada, Myso
Slide 35: Tamil Nadu Region
Tamil Nadu Region Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Nellore Nellore Chennai Tamil Nadu Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 2,039 2,022 0.8% 2,039 2,022 0.8% Bed Occupancy Rate (%) 64% 66% 64% 63% Trichy Inpatient volume 38,561 38,
Slide 36: AP, Telangana Region
AP, Telangana Region Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 1,240 1,270 -2.4% 1,240 1,270 -2.4% Bed Occupancy Rate (%) 66% 57% 68% 57% Kakinada Inpatient volume 22,035 19,099 15.4% 65,
Slide 37: Karnataka Region
Karnataka Region Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 772 750 2.9% 772 750 2.9% Bed Occupancy Rate (%) 71% 67% 75% 66% Inpatient volume 16,991 16,255 4.5% 53,221 48,222 10.4% Outpatient volume (1) 72,056 51,299 40.5% 204,319
Slide 38: Eastern Region
Eastern Region Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela Eastern Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Guwahati Operating Beds 1,867 1,812 3.0% 1,867 1,812 3.0% Bed Occupancy Rate (%) 72% 73% 75% 74% Inpatient volume 32,780 31,187 5.1% 101,156 93,479 8.2%
Slide 39: Western Region
Western Region Metro:- Navi Mumbai; Non Metro:- Nashik and Ahmedabad Western Region Ahmedabad Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 876 861 1.7% 876 861 1.7% Bed Occupancy Rate (%) 57% 57% 59% 55% Inpatient volume 13,109 13,344 -1.8% 40,195 37,523 7.1% Nashik (1) Outpatient volume
Slide 40: Northern Region
Northern Region Metro:- Delhi; Non Metro:- Lucknow and Indore Delhi Northern Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Lucknow Operating Beds 1,202 1,196 0.5% 1,202 1,196 0.5% Bed Occupancy Rate (%) 74% 70% 74% 69% Inpatient volume 27,510 24,990 10.1% 82,042 74,635 9.9% (1) Outpatient volume
Slide 41: Healthcare Services: Expansion Plan
Healthcare Services: Expansion Plan Balance Total Census Project Cost Location Nature Project Cost Beds Beds (in Crs) (in Crs) Expected commissioning : FY26 Royal Mudhol Pune Hospital Asset Acquisition 400 325 ₹ 630 ₹ 265 Sonarpur, Kolkata Hospital Asset Acquisition 270 220 ₹ 310 ₹ 150 Gachibowli, H
Slide 42: Diagnostics & Retail Health: Apollo Health & Lifestyle Ltd
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 42
Slide 43: Executive Summary
Executive Summary Primary Care Diagnostics Specialty Care Core revenues of Primary Care grew by Wellness segment volume grew by ~36% Spectra: ~18% YoY revenue growth in ~14% YoY in 9M’FY25, as a result of YoY in 9M’FY25 & contributed to ~18% of 9M’FY25 driven by operationalization of redesigni
Slide 44: AHLL Financials YTD Dec24
AHLL Financials YTD Dec24 (` mio) AHLL Revenues grew by 15% YoY in YTD Dec 24; primarily attributed to maturing Corporate / Intra network Primary Care Diagnostics Specialty Care AHLL Group Revenue 3,127 3,721 5,257 -510 11,596 Diagnostics revenue and EBITDA grew EBITDA 576 407 576 -494 1,065 by 8% a
Slide 45: AHLL Financials Q3FY25
AHLL Financials Q3FY25 (` mio) Corporate / Intra Primary Care Diagnostics Specialty Care AHLL Group Revenue 1,069 1,212 1,724 -110 3,895 AHLL Revenues grew by 15% YoY in Q3’ EBITDA 193 116 183 -150 342 FY25; primarily attributed to maturing Q3FY25 margin (%) 18.1% 9.6% 10.6% - 8.8% network EBIT 123
Slide 46: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn) EBITDA (INR Mn)1 Operational footprint (as of Dec 31, 2024) 14% 13% ~330+ 10% 9% 10% ~330+ Cities Cities presence 1,345 168 181 presence 1,122 1,169 1,164 1,212 112 110 116 1 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q
Slide 47: Digital Health & Pharmacy Distribution: Apollo HealthCo
Digital Health & Pharmacy Distribution Apollo HealthCo © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 47
Slide 48: India's Largest Omni-Channel Healthcare Platform
India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform 6,360 Stores ~16.4% Omni Private ~38 Mn+ Registrations Added - YTD 334 label / generics Chandigarh: 5 mix Himachal Pradesh: 6 Closed – YTD 4 - YTD Dec24 Uttarakhand: 35 ~10,100 Doctors Punjab: 65 Ne
Slide 49: Apollo HealthCo Financials YTD Dec24
Apollo HealthCo Financials YTD Dec24 (` mio) Online Offline Pharmacy Total Healthco (YTD Dec 24 vs YTD Dec23); ` Mio Pharmacy Distribution & HealthCo Distribution o 16% growth in revenue in YTD ’FY25 vs YTD ’FY24 Apollo 247 Total Revenues 59,299 7,868 67,167 o PAT positive in YTD ’FY25 (Rs. 382 Mn)
Slide 50: Apollo HealthCo Financials Q3FY25
Apollo HealthCo Financials Q3FY25 (` mio) Healthco (Q3’ FY25 vs Q3’ FY24); Online Offline Pharmacy Total o 15% growth in revenue in Q3’ FY25 vs Q3’ FY24 ` Mio Pharmacy Distribution & HealthCo Distribution Apollo 247 o PAT positive in Q3’FY25 (Rs. 321 Mn) vs loss of Rs. 276 Mn in Total Revenues 20,78
Slide 51: Apollo HealthCo: Advent Investment - Tranche 1 of INR 1732 crs completed
Apollo HealthCo : Advent Investment - Tranche 1 of INR 1732 crs completed • Apollo Healthco Limited (“AHL”) to raise equity capital of INR 2,475 Crs (USD 300 Mn) from Advent International (“Advent”)1, one of the largest global private equity investors with an AUM of over USD 94 Bn. Tranche 1 of INR
Slide 52: Synergetic Benefit of the Keimed Merger
Synergetic Benefit of the Keimed Merger Becoming India’s Leading Healthcare Provider 1 Leading Pharma End-to-end, Patient retention Distributor seamless, omnichannel User satisfaction + business model of pharmacy Cross selling Growing Omni distribution with a Apollo Channel Platform fast-growing dig
Slide 53: Proposed Transaction Structure and Steps (1/2)
Proposed Transaction Structure and Steps (1/2) Post Advent Tranche 1 Investment Post Advent Tranche 2 Investment Pre-Transaction (T) (T+12 Months) AHEL ESOP AHEL Advent ESOP AHEL Advent ESOP 95% 5*% 83.1% 12.5%1 4.4% 79.0% 16.9% 4.1% 2% 11.2% AHL AHL Keimed AHL Keimed Tranche 1 Tranche 2 • Advent in
Slide 54: Proposed Transaction Structure and Steps (2/2)
Proposed Transaction Structure and Steps (2/2) Launch of Merger Process Post Merger (T+15 Months) (T+30 Months) Keimed AHEL Promoters Keimed 61.5% AHEL 79.0% Shareholders Other minority Advent ESOP FHPL partners 59.2%** 25.7%# Min Max 16.9% 4.1% 16.1% 11.2% Advent ESOP 11.2%* 12.1%+ 3.0% AHL Keimed
Slide 55: Combined Financials Metrics | Snapshot YTD Dec24
Combined Financials Metrics| Snapshot YTD Dec24 (` mio) FY24 Offline Pharma Online Pharma Combined Combined Distribution Total Healthco Keimed Combined Distribution+247 YTD’FY25 Q3’FY25 Revenue 137,701 59,299 7,868 67,167 96,534 121,318 42,355 EBITDA,Pre 9,614 4,348 1,029 5,377 3,002 8,379 2,953 IND
Slide 56: Prioritizing ESG
Prioritizing ESG © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 56
Slide 57: Governance (1/4) – Skilled and Experience Board
Governance (1/4) – Skilled and Experience Board Fully Independent Board Independence Gender Diversity Our Board Committees Executive Directors Nomination & Risk Audit Remuneration Management Stakeholder 50% Independent 60% Female CSRS* Investment Relationship Share Transfer Innovation and Quality Dr
Slide 58: Governance (2/4) – Skilled and Experience Board
Governance (2/4) – Skilled and Experience Board Dr. Prathap C. Smt. Preetha Smt. Smt. Sangita Shri. MBN Smt. Kavitha Smt. Shobana Dr. Murali Smt. Rama Shri. Som Mittal Reddy Reddy Suneeta Reddy Reddy Rao Dutt Kamineni Doraiswamy Bijapurkar Chair Vice-Chair Managing Director Managing Director Lead In
Slide 59: Governance (3/4) – Governance of Sustainability
Governance (3/4) – Governance of Sustainability Our governance framework ensures that social responsibility and sustainability considerations are embedded in our decision-making process, operations and interactions with stakeholders Board-level Mechanism Accountable and Transparent Our Enterprise Ri
Slide 60: Governance (4/4) – Risk Management
Governance (4/4) – Risk Management The Board constituted a Risk Management Committee, chaired by the Managing Director, to identify elements of risk in different areas of operations and to develop a policy for actions associated to mitigate the risks. The Audit Committee, wholly independent, evaluat
Slide 61: Sustainability (1/5) – Our Strategy and Targets
Sustainability (1/5) – Our Strategy and Targets Targets & Select Metrics (see Aligning our Strategy with our Material Risks and Opportunities our FY24 ESG report for full list) • Net Promoter Score from patients of >84 for OP & IP • 100% re-accreditation for all hospitals undergoing JCI, Healing our
Slide 62: Sustainability (2/5) – Performance Highlight FY24
Sustainability (2/5) – Performance Highlight FY24 Access to Healthcare Patient Safety Water Waste • 7,151,874 patients served • In-patient and out-patient Net • c.536,000 KL of water recycled • c.4874 MT of waste recycled or • 6,000+ pharmacies Promoter Score is 84 • 1.6 million KL of water underwen
Slide 63: Sustainability (3/5) – Healing Our Patients
Sustainability (3/5) – Healing Our Patients Healing our patients through quality care, unparallelled service Pillar’s experiences, and ensuring accessibility and affordability of Purpose medicines and care services in strained geographies. 84 84 84 84 From a clinical perspective, we’ve trailblazed t
Slide 64: Sustainability (4/5) – Empowering Our People
Sustainability (4/5) – Empowering Our People Empowering our people through internal Pillar’s Positive Employee Satisfaction Survey development, policies, initiatives, external community Purpose building and CSR initiatives. On Roll Off Roll In FY23-24, we’re proud to announce our first-ever employee
Slide 65: Sustainability (5/5) – Nurturing Our Planet
Sustainability (5/5) –Nurturing Our Planet Driving sustainable outcomes through climate change Falling Scope 1&2 emissions*& Pillar’s governance and ensuring that we extend these practices 1000k Purpose across our value chain. FY22-23 FY23-24 -11% y-o-y fall in total 500k Scope 1 & 2 emissions The y
Slide 66: Dr. Prathap C. Reddy, Founder and Chairman of Apollo Hospitals
DR. PRATHAP C. REDDY Founder and Chairman of Managing our sustainability risks is not just about demonstrating goodwill to our Apollo Hospitals stakeholders; it’s about embedding sustainability into every aspect of our decision- making process. Our refined sustainability strategy, aligned with our m
Slide 67: Annexure
Annexure © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 67
Slide 68: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A
Slide 69: IND AS 116: Impact on P&L and Balance Sheet – YTD Dec24
IND AS - 116 : Impact on P&L and Balance Sheet –YTD Dec24 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset 12,803 Revenue Right of use Asset 23,896 Revenue as of Other expenses 769 as of Other expenses 1,
Slide 70: Thank you !!
Thank you !! 70
Apollo Hospitals Enterprise — Investor Presentation (December 2024) on 6ix